Abstract
BackgroundDespite currently available standard-of-care inhaled corticosteroid (ICS)/long-acting β2-agonist therapies, a substantial proportion of patients with asthma remain inadequately controlled. This pooled analysis evaluated efficacy and safety of mometasone furoate/indacaterol acetate...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have